Cleared Traditional

K802818 - PULLEN POCKET SCOPE

K802818 is an FDA 510(k) clearance for PULLEN POCKET SCOPE, manufactured by P.A. Research Corp.. The device is a Class 1 Microbiology device with product code IBJ cleared through the Traditional 510(k) pathway after a 161-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1981
Decision
161d
Days
Class 1
Risk

K802818 is an FDA 510(k) clearance for the PULLEN POCKET SCOPE. Classified as Light, Microscope (product code IBJ), Class I - General Controls.

Submitted by P.A. Research Corp. (Mchenry, US). The FDA issued a Cleared decision on April 17, 1981 after a review of 161 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 864.3600 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all P.A. Research Corp. devices

FDA 510(k) Submission Details - K802818

510(k) Number K802818 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 07, 1980
Decision Date April 17, 1981
Days to Decision 161 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
59d slower than avg
Panel avg: 102d · This submission: 161d
Pathway characteristics
Predicate-based equivalence.

IBJ Device Classification - Class 1, General Controls

Product Code IBJ Light, Microscope
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 864.3600
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.